Professor | Jianhua Sun | Asia Growth Partners

Name

Jianhua Sun

Contact Information

jhsun@cdser.simm.ac.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	University of Chinese Academy of Sciences
Faculty	Medical School
Academic Background & Achievements	2002-09 to 2007-09: PhD, Zhejiang University 1997-09 to 2001-09: Bachelor's, Hebei Agricultural University
Work Experience	2007-10 to Present: Head of New Technology Development Department, Shanghai Institute of Materia Medica, Chinese Academy of Sciences 2023-06-01 to 2024-06-30: Head of Animal Center and Deputy Director of Safety Evaluation Center, Zhongke Zhongshan Institute of Drug Innovation
Awards	Shanghai Pudong New Area Science and Technology Award, First Prize, 2016

University/Lab Affiliation and Title

University of Chinese Academy of Sciences

Faculty

Medical School

Academic Background & Achievements

Work Experience

2007-10 to Present: Head of New Technology Development Department, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
2023-06-01 to 2024-06-30: Head of Animal Center and Deputy Director of Safety Evaluation Center, Zhongke Zhongshan Institute of Drug Innovation

Awards

Areas of Focus	Toxicology Veterinary Medicine Pharmacology
Publications	Suppression of tumor or host intrinsic CMTM6 drives antitumor cytotoxicity in a PD-L1 independent manner, Cancer Immunology Research, 2023 New laboratory evidence for the association between endothelial dysfunction and COVID-19 disease progression, J Med Virol, 2022 CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity, Cell discovery, 2022

Areas of Focus

Toxicology
Veterinary Medicine
Pharmacology

Publications

Suppression of tumor or host intrinsic CMTM6 drives antitumor cytotoxicity in a PD-L1 independent manner, Cancer Immunology Research, 2023
New laboratory evidence for the association between endothelial dysfunction and COVID-19 disease progression, J Med Virol, 2022
CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity, Cell discovery, 2022

Toxicology Veterinary Medicine Pharmacology Drug Development Safety Evaluation Animal Models Pathogen Detection Immunology Cancer Research Covid-19

Yong Tian - University of Chinese Academy of Sciences

Guoyuan Chen - University of Chinese Academy of Sciences

Wei Pang - University of Chinese Academy of Sciences

View All

Personal Information